Home > Boards > US OTC > Delisted >

Calypte Biomedical Corporation (fka CBMC)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/4/2018 11:47:22 AM - Followers: 108 - Board type: Free - Posts Today: 0

Calypte Biomedical Corporation
15875 SW 72nd Ave
Portland, OR 97224
Tel: 503-726-2227503-726-2227
Fax: 503-601-6299
Toll Free: 877-CALYPTE877-CALYPTE


Ticker Symbol: CBMC.OB
Listed on NASD Over the Counter Bulletin Board

Our subsidiary Beijing Marr


BioPharma FZE is based in Dubai (United Arab Emirates) 



In the fight against disease, knowledge is power – for individuals, communities and nations. To help in the battle, Calypte Biomedical Corporation develops innovative in vitro diagnostic testing solutions for HIV and other infectious diseases.

Our reliable, non-invasive HIV diagnostic tests and specialty research tools are helping doctors and scientists improve health and health care around the world.


Calypte Biomedical Corporation develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection, sexually transmitted diseases and other chronic diseases.Aware™ HIV-1/2 OMT is such type of product.Our innovative product line includes both point-of-care rapid tests and traditional EIA diagnostic tests.

Founded in 1988, Calypte is a pioneer in non-blood-based HIV antibody testing. We’re the first and only company to earn approval from the U.S. Food and Drug Administration for a urine-based HIV-1 antibody-screening test and supplemental Western blot.Today, our Aware™ family of rapid oral fluid HIV tests offers unrivalled HIV 1/2 testing flexibility in a non-laboratory setting.

Calypte is also the licensed manufacturer of a quantitative enzyme immunoassay developed by the U.S. Centers for Disease Control and Prevention (CDC) that can discriminate between recent and established HIV-1 infections. Designed for use in epidemiology, the Aware™ BED™ EIA is a practical way to determine HIV-1 incidence (the rate of new infections). Because it uses cross-sectional rather than longitudinal sampling and is based on direct biomarker evaluation, the BED EIA can provide incidence information much more rapidly than traditional methods such as cohort studies.  Since its introduction in 2004 (formerly under the name BED HIV-1 Incidence EIA), the Aware™ BED™ EIA has gained widespread favor with government institutions and HIV intervention programs worldwide as a tool for better allocating resources, measuring program success and targeting HIV hot spots.

Working through a network of national and regional distributors Calypte continues to broaden the reach of its products. We plan to launch a new line of rapid HIV antibody tests in the United States and other developed nations using a novel lateral flow platform technology and we remain committed to bringing new products to developing regions where the need is acute for accurate, innovative HIV testing methods.

To meet this demand with maximum quality and efficiency, we’ve added manufacturing capacity through a contract with an ISO-certified manufacturer in Thailand and a cGMP certified manufacturer in the USA.

Publicly held, Calypte trades on the OTCBB under the symbol “CBMC.”


Calypte Life Sciences offers innovative and unique products for improving the performance of immunoassays. Whether for rapid test or ELISA platforms, Calypte Life Sciences products improve immunoassays by strengthening signal, reducing background, and optimizing antigen-antibody binding. Calypte Life Sciences also offers highly purified recombinant proteins and antigens for a wide range of applications including HIV, Influenza, Dengue Fever, Hepatitis C and others.


Sampling Device

In the first quarter of 2008, we introduced our Aware TM Messenger TM oral fluid sample collection device. This collection device is based on the same principle as employed in our Aware TM HIV-1/2 OMT test. This product can be used to collect oral fluid analytes for not only HIV antibodies, but also for hepatitis antibodies, drugs of abuse and certain genetic screening applications, among others. Our initial target for this product is the life insurance risk assessment market.

Aids 2008 MEXICO


Aware Messenger™

Ken Clark International
Start-Up & Fast Growth Client List


Calypte® HIV-1 BED Incidence EIA &

Calypte® HIV-1 BED Incidence EIA (Dried Blood Spot Testing)

(Enzyme Immunoassay for Population Estimates of HIV-1 Incidence) 

Brochure:  www.calypte.com/pdf/bed-sell-sheet-final.pdf

Eurosurveillance, Volume 13, Issue 36, 04 September 2008  






HIV/AIDS testing market to exceed $3.9 billion by 2015, according to new report by Global Industry Analysts, Inc.

Key players in world HIV/AIDS testing market with significant presence include Abbott Laboratories Inc., Adaltis Inc., Siemens Healthcare Diagnostics Inc., Biomérieux SA, Bio-Rad Laboratories Inc., Calypte Biomedical Corporation, Celera Group, Gen-Probe Inc., Innogenetics NV, MedMira Laboratories, Inc., Medical Services International Inc., OraSure Technologies Inc., Ortho-Clinical Diagnostics Inc., and Roche Diagnostics. In the rapid testing market, key participants comprise Orasure, Trinity Biotech, Calypte Biomedical Corporation, Medical Services International Inc., and MedMira. OraSure Technologies, Inc. leads the market for oral fluid diagnostics worldwide.



A laboratory cost analysis between the AWARE TM test kits and other available kits in Cameroon showed that the AWARE TM HIV1/2 OMT had a total per patient cost of  $4.72 compared to $7.33 + 0.11, the mean cost of other tests and was the safest and easiest to use when compared with other blood and oral fluid test kits (Table 3).



Effective in January 2006, Calypte became the 51% owner of Beijing Marr Bio-Pharmaceutical Co., Ltd. ("Beijing Marr"). We purchased our equity interest from Marr Technologies Asia Limited ("Marr Asia"), an affiliate of Marr. Marr Asia continues to own the remaining 49% interest in Beijing Marr. Through our acquisition of Beijing Marr, we have acquired rights to manufacturing facilities and other assets necessary to manufacture our AwareTM line of HIV-1/2 rapid test products in China. Beijing Marr is currently renovating the manufacturing facilities, completing the transfer of assets it purchased from Beijing Yaohua Bio-Technology Ltd. (the "Yaohua Assets") and obtaining the necessary governmental approvals to begin production of our AwareTM HIV-1/2 rapid oral fluid (OMT) diagnostic test, which is currently under evaluation by the Chinese State Food and Drug Administration ("SFDA"). (10KSB)

The Chinese Beijing Calypte-Marr Web-Site :


The company acquired manufacturing facilities in Huairou with a planned production capacity of up to 100 million HIV rapid tests per year.

In November of 2007, the company successfully gained the certificate of ISO 9001:2000, a Quality Management System and ISO 13485:2003, Medical Devices-Quality Management Systems.

The company commits to provide the rapidest and the most accurate method to detect infectious diseases for humanity and focuses on developing and producing test reagent for detecting HIV-1/2 antibody. The company introduced the Aware™ HIV-1/2 OMT test to China and is longing to contribute to the fight against HIV/AIDS in China.


On 2009-02-25 Calypte Receives Public Security Bureau Report

Our company got the Public Security Bureau report from Evidence Evaluation Center for our product 'Anti-Human Immunodeficiency Virus Antibody Human Oral Mucosal Transudate Dianostic Kit (Colloidal Gold)' on Feb 20, 2009.

Building Pictures of Beijing Calypte Biomedical Technology Ltd. Calypte is the 51% owner of Beijing Marr Bio-Pharmaceutical Co., Ltd. ("Beijing Marr").

Number of Employees in China:


Huairou district is located in northeast of Beijing with a distance of 50 kilometers from the city area. It is 32 kilometers from the Beijing International Airport, and 170 kilometers from Tianjin Harbor. To its north is Yanshan Mountains and to the south is North China Plain covering an area of 2128.74 square kilometers with a population of 270,000. Beijing Yaohua Bio-Technology Ltd is located in Huairou district with annual sales more than 100 million Yan ($12 Million Dollar). In May 2005, Beijing Marr Bio-Pharmaceutical Co., Ltd. was incorporated in Huairou district. In December 2005, Beijing Marr Bio-Pharmaceutical Co bought Beijing Yaohua Bio-Technology Ltd. In January 2006, Calypte became the 51% owner of Beijing Marr Bio-Pharmaceutical Co., Ltd.

June 15, 2009…AIDS saliva examination indicator paper will promote gradually


 Calypte has approvals in the following countries:

May 16, 2005
Test(s) Approved: Aware® BSP, OMT
Population: 26 million
Infected: 530,000
Number tested in 2004: 1 million

September 15, 2005
Test(s) Approved: Aware® BSP
Population: 13 million
Infected: 1.8 million

October 11, 2005
Test(s) approved: Aware® BSP
Population: 24 million
Infected: 55,000

United Arab Emirates
January 19, 2006
Test(s) Approved: Aware® OMT OTC
First OTC Rapid HIV Test in the world
No. of Countries: 22 Middle East
Population: 465 Million
Infected: 230,000 to 1.5 million

March 28, 2006
Test(s) Approved: Aware® BSP, OMT
Population: 30 million
Infected: 1.2 million

South Africa
April 24, 2006
Test(s) Approved: Aware® BSP, OMT
Population: 44,187,637
Infected: 6.29 million

USAID Waiver List
Test(s) Approved: Aware® BSP, OMT HIV-1/2


Russian Federation
Unknown approval date.
Test(s) Approved: Aware® OMT PRO & OTC
Population: 142,893,540
Infected: 860,000 Adults

July 11, 2007
Test(s) Drug Control Authority of India ("DCAI") Registration & Marketing Approval: Aware® HIV-1/2 OMT PRO
Population: 1.1 billion
Infected: 2.5 million

April 17, 2008
State Food and Drug Administration ( "SFDA" ) of China
Test(s) Approved: Aware® HIV-1/2 OMT
Population: 1.3 billion
Cote d'Ivoire
September 2008
Test(s) Approved: Aware® HIV-1/2 OMT
4Q 2008
Test(s) Approved: Aware® HIV-1/2 OMT
4Q 2008
Test(s) Approved: Aware® HIV-1/2 OMT
4Q 2008
Test(s) Approved: Aware® HIV-1/2 OMT

Company Information view SEC File


Recent News :




Google Search Calypte - AWARE OMT in China :


Aware OMT HIV-1/2 Rapid Test in a diverse population. The test performed within the defined specifications



Aware™ HIV-1/2 (oral fluid) test

on Asian (Chinese) websites for OTC sales.









Video about Aware™ HIV-1/2 (oral fluid) test and Humanwell Healthcare Group


-- NEW Strategic investor -- 

Humanwell Medical Group, will open a new Chinese HIV saliva test reagent market chapter 

Humanwell Healthcare Group
Market Cap.  $1.76 B 



Humanwell Medical Explorers is a keen sense of smell, the reporter learned that the company through two equity acquisition in the first half, its subsidiaries and biological Wuhan Foxit Biopharmaceutical Co., Ltd. held by Beijing Marr 62.5% stake, has become a strategic investor Beijing Marr organisms. And as the first  HIV saliva test strip manufacturers (Beijing Marr) whose Aware Saliva HIV test reagents, in 2008 became the first State Food and Drug Administration registration and access to USAID (United States Agency for International Development) certification. Some analysts believe that, had not been involved in this business Humanwell medicine, it is expected to achieve through the acquisition directly into biological Beijing Marr HIV rapid test market purposes. 






2011: MarrBio and Pharmaceutical Group Humanwell depth cooperation, Humanwell Pharmaceutical Group to become a strategic investor MarrBio organisms, biological and Shimano combination Humanwell Medical Group, will open a new Chinese HIV saliva test reagent market chapter.

MarrBio always adhering to the "quality of life, precisely from responsibility" concept, has passed the ISO13485, ISO9001 international quality system certification. MarrBio organisms with first-class team of scientists, chief scientist of the U.S. presence, the appointment of senior long-term production experts and American scientists regularly scheduled staff training; Marr biological carefully selected leading international business as a supplier of raw materials from the world's leading laboratory Preparation; Marr biological quality assurance throughout the entire production process, including audit suppliers, raw materials procurement, purchase of materials distributed storage, intermediates and all aspects of the preparation of semi-finished and finished products factory, etc., to achieve the whole process of production checks.

MarrBio is committed to the cause of China's AIDS Prevention, CDC-oriented VCT clinics, hospitals, NGO organizations and HIV risk groups, in order to quality products and personalized service, to provide users with non-invasive and painless, safer, more intimate, Faster, accurate HIV testing experience. Future medical conditions and for a limited blood difficult areas, specific populations difficult interventions, aware Ai Wei products will take further advantage of the implementation of corporate social responsibility, responsiveness and support the Chinese government "to expand the coverage of surveillance and testing to maximize discovery of HIV infection who "policy for China to make a positive contribution to the cause of AIDS!

Calypte Biomedical company founded in 1988, has become the market of non-invasive detection of HIV antibodies in the field of pioneers. In order to HIV1 / 2 antibody test non-laboratory environments provide a traditional blood test reagents do not have the flexibility, including the Portland-based company launched Pood urine, oral mucosal exudate, blood samples for HIV testing reagents its Western blotting detection reagent is the nation's first FDA-approved similar products. Aware™ HIV-1/2 has been carried out on a global scale clinical trials over 8600 cases, experiments show that the accuracy Aware™ HIV-1/2 reached 99.8%, the accuracy and rapid blood test reagent is quite excellent.

Humanwell Pharmaceutical Group was established in 1993, in 1997 and listed on the Shanghai Stock Exchange. After nearly 20 years of development, human welfare medicine has become integrated pharmaceutical group, under the jurisdiction of more than 10 pharmaceutical companies and a number of pharmaceutical commercial enterprises, has become China's pharmaceutical industry hundred enterprises, state-level enterprise technical centers, has been anesthetic in the country, the field of fertility regulation medicine, Uygur medicine has established a leadership position. As a "National Enterprise Technology Center", "National Key New Drug Creation of special commitment units", the company adhere to the research and development for the pilot, ongoing R & D investment, with the famous research institutions have established close ties and cooperation platform, and with the Chinese military Academy of Medical Sciences established the "Optics Valley of Military Sciences innovative drug research and development center."



















This message board is used by Calypte stockholders and anyone who would like to make comments, ask questions or provide information related to the stock. If you are new to this board we welcome you and look forward to civil discussions. Any message using profanity, racial slurs or personal attacks will be removed. Please do not give personal information on this board, if you wish to do so please use the "Private Reply" button located in the top of each message screen.

*Sensitivity is a measure of the number of infected subjects correctly identified as positive
*Specificity is a measure of the number of uninfected subjects correctly identified as negative
*Accuracy is a composite measure of how many of the test subjects were correctly classified as infected or uninfected

PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#14825   this pizzin stock has friends in Halifax , ernie44 09/04/18 11:47:21 AM
#14824   A bad lawyer can let a case drag ernie44 09/29/16 11:36:58 PM
#14823   Urologists have to pee with the equipment they have ernie44 09/29/16 11:33:33 AM
#14822   When naked pumpers referred to calypte as a ernie44 09/27/16 02:53:36 PM
#14820   And? rawiron1 03/21/16 02:21:53 PM
#14819   Whooo Hooo! Great News! cato___ 06/04/15 09:19:59 AM
#14818   I am aware it's not the SEC's fault mc6102 04/08/15 05:35:35 AM
#14817   It's not the sec fault...they let these guy The_Free_Nebula 04/08/15 12:01:59 AM
#14816   I have been "warned" on every stock I've mc6102 04/07/15 09:14:40 AM
#14815   I warned you thusly. Remember when you cato___ 04/07/15 09:12:16 AM
#14814   Goodnight.....forever CBMC. Snizzle 04/06/15 06:06:42 PM
#14813   Thanks for the "protection" SEC!!! You're the best! mc6102 04/06/15 02:12:23 PM
#14812   "Maybe they'll cut me a check for 50 mc6102 04/06/15 11:57:09 AM
#14811   I'm only out $258. rawiron1 04/06/15 10:58:53 AM
#14810   CBMC revoked: Renee 04/06/15 09:32:12 AM
#14809   "Class Action, anyone? " Definitely in on that if Snizzle 04/03/15 11:12:59 PM
#14808   They are probably happy to get revoked. mc6102 04/03/15 10:39:31 PM
#14807   It was done via the telephone......there was no Snizzle 04/03/15 09:52:15 PM
#14806   Bus Fare. There is no money to attend. cato___ 04/03/15 05:26:55 PM
#14805   ..did not attend!! Scheilko 04/03/15 02:47:50 AM
#14804   It doesn't to the SEC and that's what MIKE2OO5 04/02/15 09:55:28 PM
#14802   Pretty damn sure .001 is a great price. Snizzle 04/01/15 08:13:14 PM
#14801   you are happy with 001 ??? Abondanceinvest 04/01/15 08:00:13 AM
#14800   0015 Tonyeight 03/27/15 04:26:45 PM
#14799   it is all good bro one man Tonyeight 03/27/15 02:16:42 PM
#14798   ??? What are you talking about? Volume mc6102 03/27/15 02:11:48 PM
#14797   one buy @0017 other was SALE bro <<<<<<<<<< 0015 Tonyeight 03/27/15 02:05:34 PM
#14796   Wow, another 690K bought today so far. mc6102 03/27/15 12:40:29 PM
#14795   001 === 0015 ===0017 ===?????????????????? Tonyeight 03/26/15 10:42:32 AM
#14794   Continues to roll The_Free_Nebula 03/26/15 10:21:25 AM
#14793   nah, was never gonna sell. No point. mc6102 03/25/15 04:48:46 PM
#14792   I'm out already......eating tuna , no bread for Snizzle 03/25/15 02:51:25 PM
#14791   CBMC Oh Yee of little faith! Hope U Xzibit 03/25/15 01:49:09 PM
#14790   ok then =wait till april fool day Tonyeight 03/25/15 01:37:19 PM
#14789   Yes sir, I know. Just letting everyone know Snizzle 03/25/15 01:08:48 PM
#14788   All I know is that those that held The_Free_Nebula 03/25/15 12:54:47 PM
#14787   No ruling found anywhere on SEC site yet. mc6102 03/25/15 12:36:18 PM
#14786   How could that have happened if the pre-hearing mc6102 03/25/15 12:28:09 PM
#14785   Heard something about a court ruling for CBMC Snizzle 03/25/15 12:23:38 PM
#14784   SOMETHING IS COOKING BEHIIND THE DOOR>>>>> WONDER Tonyeight 03/25/15 11:17:10 AM
#14783   another =DELAYING ???????????????? Tonyeight 03/23/15 10:34:16 AM
#14782   NOTHNG GONNA HAPEN ON APRILBY THE COMPANY Tonyeight 03/23/15 10:24:34 AM
#14781   ADMINISTRATIVE PROCEEDINGS RULINGS Scheilko 03/23/15 10:20:42 AM
#14780   HANGGING THERE FOR WHAT REASON BRO +PLESE EXPLAIN????????sevenandcounting Tonyeight 03/23/15 09:26:53 AM
#14779   CBMC IS DONE FELA ((((((( NO HOPE Tonyeight 03/22/15 07:02:42 PM
#14778   Just hang in there guys. Wonders are in sevenandcounting 03/21/15 09:17:17 PM
#14777   Well said MC---well said... Yourstomine 03/20/15 07:53:34 PM
#14776   CBMC not worth selling for me -- not mc6102 03/20/15 07:15:51 PM
#14775   CBMC IS PUT REST FOR GOOD COMING SAL Tonyeight 03/20/15 06:42:19 PM